PMA device
Gem III At ICD
Medtronic, Inc. · Implantable Cardioverter Defibrillator (Non-Crt) (LWS, Class III) · First FDA decision Feb 21, 2003, newest Aug 7, 2016Ventricular arrhythmia and sudden cardiac arrest
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
0
Naming "Gem III At"
MAUDE reports
4
Brand "Gem III At", since 2015
PubMed studies
0
Mentioning "Gem III At"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Gem III At ICD
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
- GEM III AT ICDPMA supplement
P980050-S104 · Decided Aug 7, 2016 · 67 days after receipt · Normal 180 Day Track
Device type: Implantable cardioverter defibrillator (non-CRT) (LWS) · Cardiology
- GEM III ATPMA supplement
P980050-S076 · Decided Oct 26, 2012 · 80 days after receipt · Normal 180 Day Track
Device type: Implantable cardioverter defibrillator (non-CRT) (LWS) · Cardiology
- GEM III AT ICDPMA supplement
P980050-S035 · Decided Nov 21, 2008 · 116 days after receipt · Normal 180 Day Track
Device type: Implantable cardioverter defibrillator (non-CRT) (LWS) · Cardiology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Implantable Cardioverter DefibrillatorsNational analysisReview closedCAG-00157R4Updated Nov 19, 2026
- Implantable Cardioverter Defibrillators (ICDs)National determinationOn the books20.4Updated Sep 28, 2026
- Implantable Cardioverter Defibrillators (ICDs)National analysisReview closedCAG-00157NUpdated Sep 15, 2026
- Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web BasedLocal determinationIn effectL34087CGS Administrators, LLCUpdated Aug 28, 2026
- Implantable DefibrillatorsNational analysisReview closedCAG-00157R2Updated Nov 19, 2026
- Implantable Defibrillators - Clinical TrialsNational analysisReview closedCAG-00157RUpdated Sep 15, 2026
- Implantable DefibrillatorsNational analysisReview closedCAG-00157R3Updated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Gem III At", any status and sponsor, newest update first.
No registered device study names "Gem III At".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Gem III At", and for the whole product code for context.
This brand
4 reports: 0 malfunction, 4 injury, 0 death
Whole product code LWS
240,687 reports: 89,252 malfunction, 148,026 injury, 3,316 death
Newest reports for this brand
- GEM III ATInjury
2182208-2018-02322 · Received Dec 21, 2018 · Event dated May 1, 2006
Device type: Implantable Cardioverter Defibrillator (Non-Crt) (LWS)
Device problem as coded: Over-Sensing; Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem
Patient problem as coded: Ventricular Tachycardia; Shock from Patient Lead(s)
- GEM III ATInjury
9614453-2018-02581 · Received Jul 17, 2018 · Event dated Sep 15, 2010
Device type: Implantable Cardioverter Defibrillator (Non-Crt) (LWS)
Device problem as coded: Product Quality Problem; Adverse Event Without Identified Device or Use Problem
Patient problem as coded: No Known Impact Or Consequence To Patient
- GEM III ATInjury
MDT PUERTO RICO OPERATIONS CO, MED REL
2647346-2018-00027 · Received Jun 20, 2018 · Event dated Jan 23, 2006
Device type: Implantable Cardioverter Defibrillator (Non-Crt) (LWS)
Device problem as coded: Appropriate Device Problem Term/Code Not Available
Patient problem as coded: No Known Impact Or Consequence To Patient
1 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Gem III At"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LWS.
- Evera MRI XT DR SureScan Model DDMB1D4Medtronic Cardiac Rhythm Disease Management · PMA 2022
- CurrentAbbott Medical · PMA 2026
- Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)Boston Scientific Corporation · PMA 2022
- Evera S Dr,s Vr Xt Dr, Xt Ve,icd'sMedtronic Cardiac Rhythm Disease Management · PMA 2016
- EMBLEM S-ICD Electrode (Lead) Model 3501Boston Scientific Corporation · PMA 2026
- Entrust ICDMedtronic Cardiac Rhythm Disease Management · PMA 2014
- ENDOTAK RELIANCE / RELIANCE 4-FRONT pace/sense defibrillation leadsBoston Scientific · PMA 2026
- Sprint Quattro Secure S MRI Surescan Lead Model 6935M,SPRINT Quattro Secure MRI Surescan Lead Model 6947MMedtronic, Inc. · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.